Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A prominent no-show

Executive Summary

No one from GlaxoSmithKline attended the PhRMA annual meeting. GSK's board representative, Robert Ingram, participated in the March 27 board meeting via teleconference. GSK explained that "logistics" prevented anyone from attending in person. Ingram retired from day-to-day operations at GSK in December, but he is continuing to represent the company within PhRMA while working part time as vice chairman-pharmaceuticals (1"The Pink Sheet" Oct. 21, 2002, p. 27)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS041547

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel